EPHB2 and colorectal carcinoma: miR-31 has emerged as a potential driver for the colon oncogenesis via targeting EphB2 and EphA2 signaling pathways associated with the regulation of stemness, differentiation, tumor heterogeneity, and poor therapeutic outcomes in CRC patients [63].